Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 3/20 | 0.64 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7673656 | 0.87 | SLC6A3 (0.68) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9260012 | 0.86 | SLC6A3 (0.76) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL9260009 | 0.86 | SLC6A3 (0.76) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7664902 | 0.86 | SLC6A3 (0.60) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7355992 | 0.86 | SLC6A3 (0.76) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7355995 | 0.86 | SLC6A3 (0.76) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL13595971 | 0.84 | SLC6A2 (0.81) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL14184220 | 0.81 | SLC6A3 (0.55) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7355978 | 0.80 | SLC6A3 (0.64) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL7363266 | 0.80 | SLC6A3 (0.64) | SLC6A2SLC6A4SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6350758-B1 | NOVEL ANALOGS OF COCAINE, ENHANCED ANALGESIC AND/OR VASOCONSTRICTIVE PROPERTIES, INHIBIT THE UPTAKE OF DOPAMINE OR SEROTONIN SO USEFUL FOR TREATING PARKINSON'S DISEASE, DEPRESSION, OR OBESITY, TREATING COCAINE ABUSE, COCAINE | GEORGETOWN UNIVERSITY | 2002-02-26 | — | — | US | disclosed |